Ophthalmic indications of amniotic membrane transplantation in Mexico: an eight years Amniotic Membrane Bank experience
- PMID: 26675894
- DOI: 10.1007/s10561-015-9540-7
Ophthalmic indications of amniotic membrane transplantation in Mexico: an eight years Amniotic Membrane Bank experience
Abstract
Amniotic membrane, the inner layer of the placenta, has biological properties (e.g. promotes epithelization, reduces fibrosis, secretes antimicrobial products and inhibits immune responses) which make it a useful option for several ophthalmologic procedures, especially those involving the ocular surface. Its use in eye surgery has been reported by other authors. To our knowledge, there is a lack of descriptive studies on surgical indications using amniotic membrane in Mexican population. Here we describe the eight years Amniotic Membrane Bank experience in Mexico, including a detailed protocol of the donors selection, tissue harvesting, preparation, storage and distribution of amniotic membrane since its establishment in 2007. Moreover, we describe the Ophthalmological indications of amniotic membrane transplantation of the total of 1686 amniotic membranes fragments used during eight years. The five most common indications for amniotic membrane transplantation were pterygium (46 %), corneal ulcers (12.6 %), conjunctival surface repair (11.1 %), neoplasms (7.4 %), and persistent epithelial defects (7.3 %). In addition, we compared the indications of amniotic membrane use in two different types of Institutions: general hospitals and ophthalmologic reference hospitals. We found interesting differences between the indications and use rates between these institutions, although pterygium was the most frequent pathology that amniotic membrane fragments were used in both institutions, there was up to a five-fold increase in the use of amniotic membrane for correction of persistent epithelial defects in reference hospitals which could be explained due to the more complex and severe ophthalmological pathologies admitted in reference hospitals. In conclusion, Amniotic Membrane is used in a numerous ocular pathologies and especially on pterygium in our Mexican population.
Keywords: Amniotic Membrane Bank; Mexico; Ophthalmic indications; Pterygium.
Similar articles
-
Amniotic membrane properties and current practice of amniotic membrane use in ophthalmology in Slovenia.Cell Tissue Bank. 2014 Jun;15(2):177-92. doi: 10.1007/s10561-013-9417-6. Epub 2013 Dec 19. Cell Tissue Bank. 2014. PMID: 24352631 Review.
-
Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting-a review.Cell Tissue Bank. 2017 Jun;18(2):193-204. doi: 10.1007/s10561-017-9618-5. Epub 2017 Mar 2. Cell Tissue Bank. 2017. PMID: 28255771 Review.
-
[Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].J Fr Ophtalmol. 2001 Oct;24(8):798-812. J Fr Ophtalmol. 2001. PMID: 11894530 French.
-
Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders.Indian J Ophthalmol. 2007 Jul-Aug;55(4):251-60. doi: 10.4103/0301-4738.33036. Indian J Ophthalmol. 2007. PMID: 17595472 Review.
-
Effect of recombinant epidermal growth factor on ocular surface re-epithelization following amniotic membrane transplantation in patients with pterygium excision.Di Yi Jun Yi Da Xue Xue Bao. 2002 May;22(5):437-8. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12390708 Clinical Trial.
Cited by
-
Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.Stem Cells Transl Med. 2018 Dec;7(12):906-917. doi: 10.1002/sctm.18-0042. Epub 2018 Sep 10. Stem Cells Transl Med. 2018. PMID: 30260581 Free PMC article.
-
Research on the construction of corneal endothelium transplantation with acellular amniotic membrane as a scaffold.Front Med (Lausanne). 2025 Jul 1;12:1592123. doi: 10.3389/fmed.2025.1592123. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40665979 Free PMC article.
-
Human Amniotic Membrane Mesenchymal Stem Cells inhibit Neutrophil Extracellular Traps through TSG-6.Sci Rep. 2017 Sep 29;7(1):12426. doi: 10.1038/s41598-017-10962-2. Sci Rep. 2017. PMID: 28963485 Free PMC article.
-
Can Human Oral Mucosa Stem Cells Differentiate to Corneal Epithelia?Int J Mol Sci. 2021 Jun 1;22(11):5976. doi: 10.3390/ijms22115976. Int J Mol Sci. 2021. PMID: 34205905 Free PMC article.
-
Efficacy of Adjunctive Bioactive Materials in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis.Biomed Res Int. 2018 May 27;2018:8670832. doi: 10.1155/2018/8670832. eCollection 2018. Biomed Res Int. 2018. PMID: 29977919 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical